Unding, Farida .

HRN: 00-11-60  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/24/2023
CEFUROXIME 1.5GM (VIAL)
02/24/2023
02/24/2023
IVTT
1.5gm
LD
For Stat Cs
Waiting Final Action 
02/24/2023
AMPICILLIN 1GM (VIAL)
02/24/2023
02/24/2023
IVTT
2gm
LD
Stat Cs
Waiting Final Action 
02/24/2023
CEFUROXIME 1.5GM (VIAL)
02/24/2023
02/25/2023
IV
1.5 G
Q8x 3 Doses
Sp LTCS
Waiting Final Action 
02/25/2023
CEFUROXIME 500MG (TAB)
02/25/2023
03/04/2023
ORAL
500mg/tab
BID
S/P LTCS
Waiting Final Action 
02/25/2023
CEFTRIAXONE 1G (VIAL)
02/25/2023
02/28/2023
IV
2G
OD
Sp LTCS
Waiting Final Action 
03/02/2023
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
03/02/2023
03/08/2023
IV
500mg
OD
Respiratory Failure Prob Massive PE-intubated
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: